Latest news
Invitation to first quarter 2017 presentation
Oslo, 5 May 2017 – PCI Biotech invites to a presentation of the company’s first quarter 2017 report on Tuesday 16 May 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday May 16, 09am – 10am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo […]
Employee share option scheme
Oslo, 5 May 2017 – In accordance with the authorisation granted by the Annual General Meeting 19 May 2016, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 340,000 share options to key employees. Each share option gives the right to subscribe for or acquire one share per option (after PCI […]
Annual Report 2016
Oslo, Norway, April 25, 2017 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2016, including the complete 2016 Annual Accounts with notes. The report is attached below. PCI Biotech Holding ASA Annual Report 2016 For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Per Walday, […]